Related Experiment Video
Updated: Jul 19, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Plasma leptin levels in patients with floppy eyelid syndrome
Mehryar Taban1, Mehran Taban, Julian D Perry
1Department of Ophthalmology, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Purpose:
To determine the range of plasma leptin levels in patients with floppy eyelid syndrome (FES).
Methods:
This was a retrospective, noninterventional case series of 11 patients with FES. Charts were reviewed for patient age, sex, plasma leptin level, body mass index (BMI), presence or absence of obstructive sleep apnea (OSA) and diabetes mellitus, and any treatments for OSA.
Results:
Charts of 11 patients were reviewed (10 male, 1 female). Plasma leptin levels were elevated in 7 of 11 patients (64%). Mean plasma leptin concentration was 49.5 ng/ml in male patients (range, 5 to 120 ng/ml) compared with a normal range of 1 to 35 ng/ml. Plasma leptin level in the female patient was 180 ng/ml (normal range, 4 to 72 ng/ml). Five patients had a known diagnosis of OSA. Four of these patients received continuous positive airway pressure during leptin level measurement. Plasma leptin levels averaged 110.0 ng/ml in the continuous positive airway pressure group. Average BMI was 37.4 kg/m (range, 24.9 to 57.1 kg/m). All patients with elevated leptin levels had a high BMI.
Conclusions:
Patients with FES demonstrate elevated plasma leptin levels, which correlate with BMI. Hyperleptinemia may play a role in the pathogenesis of FES.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Nephrotic Syndrome I : Introduction
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

